Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI.

5-HT2A 5-HT2C Psychedelics claustrum electrophysiology serotonin

Journal

Progress in neurobiology
ISSN: 1873-5118
Titre abrégé: Prog Neurobiol
Pays: England
ID NLM: 0370121

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 06 02 2024
revised: 03 07 2024
accepted: 25 08 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 1 9 2024
Statut: aheadofprint

Résumé

Recent evidence indicates that neuronal activity within the claustrum (CLA) may be central to cellular and behavioral responses to psychedelic hallucinogens. The CLA prominently innervates many cortical targets and displays exceptionally high levels of serotonin (5-HT) binding. However, the influence of serotonin receptors, prime targets of psychedelic drug action, on CLA activity remains unexplored. We characterize the CLA expression of all known 5-HT subtypes and contrast the effects of 5-HT and the psychedelic hallucinogen, 2,5-dimethoxy-4-iodoamphetamine (DOI), on excitability of cortical-projecting CLA neurons. We find that the CLA is particularly enriched with 5-HT2C receptors, expressed predominantly on glutamatergic neurons. Electrophysiological recordings from CLA neurons that project to the anterior cingulate cortex (ACC) indicate that application of 5-HT inhibits glutamate receptor-mediated excitatory postsynaptic currents (EPSCs). In contrast, application of DOI stimulates EPSCs. We find that the opposite effects of 5-HT and DOI on synaptic signaling can both be reversed by inhibition of the 5-HT2C, but not 5-HT2A, receptors. We identify specific 5-HT receptor subtypes as serotonergic regulators of the CLA excitability and argue against the canonical role of 5-HT2A in glutamatergic synapse response to psychedelics within the CLA-ACC circuit.

Identifiants

pubmed: 39218140
pii: S0301-0082(24)00096-0
doi: 10.1016/j.pneurobio.2024.102660
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102660

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tanner L Anderson (TL)

University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, Kentucky 40536.

Jack V Keady (JV)

University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, Lexington, Kentucky 40536.

Judy Songrady (J)

University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, Lexington, Kentucky 40536.

Navid S Tavakoli (NS)

University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, Kentucky 40536.

Artin Asadipooya (A)

University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, Kentucky 40536.

Ryson E Neeley (RE)

University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, Kentucky 40536.

Jill R Turner (JR)

University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, Lexington, Kentucky 40536.

Pavel I Ortinski (PI)

University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, Kentucky 40536. Electronic address: pavel.ortinski@uky.edu.

Classifications MeSH